ArticlePloS one2025
Long-term outcomes after revascularization surgery for adult moyamoya disease: Protocol for systematic review and meta-analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMoyamoya disease (MMD) commonly presents with cerebral ischemia or hemorrhage. Revascularization surgery, including direct, indirect, and combined bypasses, remains the mainstay of MMD treatment aiming to reduce stroke recurrence. However, the long-term outcomes of these interventions are still controversial. Herein, we designed the protocol for a systematic review and meta-analysis comparing the three different revascularization surgeries in adult MMD patients for more than 5 years long-term outcomes.
methodsOur systematic review and meta-analysis protocol follows the PRISMA-P guidelines. Bypass surgeries for MMD will be included only if the follow-up time is more than 5 years. The primary outcome is the incidence of recurrent cerebral ischemia or hemorrhage. The secondary outcomes include functional outcomes evaluated by the Moyamoya Disease outcome category, mortality, and angiographic outcomes such as bypass patency, and collateral formation.
resultsStudies on the postoperative outcomes of revascularization surgeries to treat adult MMD patients will be included and analyzed. This systematic review and meta-analysis will offer evidence to clinicians and researchers on the long-term outcomes of revascularization surgeries in adult MMD patients and help to optimize the selection of bypass modality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.